InvestorsHub Logo
Followers 0
Posts 157
Boards Moderated 0
Alias Born 01/27/2010

Re: KissMyCash post# 31276

Thursday, 09/09/2010 5:51:45 PM

Thursday, September 09, 2010 5:51:45 PM

Post# of 59722
I do not believe that trading will be halted nor do I believe that they even have the power to halt it. I believe that the market will determine the price and that possibly MMs may momentarily hesitate placing trades as they get their ducks in a row, but not halt anything.

From pinksheets.com:

Trade Halts

Pink OTC Markets does not halt quotation or trading in OTC Equity securities. The authority to halt trading in the OTC marketplace is limited exclusively to FINRA and the U.S. Securities and Exchange Commission. Pursuant to FINRA Rule 6660, in circumstances in which it is necessary to protect investors and the public interest, FINRA has been granted authority to halt trading and quotations in OTC securities in the following circumstances:

Foreign Market/Regulatory Halt (Note that foreign regulators are under no obligation to notify FINRA of halts in their markets and that FINRA will not halt trading in conjunction with foreign halts that are imposed solely for material news, a regulatory filing deficiency, or operational reasons);
Component/Derivative of Exchange-Listed Security;
Extraordinary Events (FINRA determines that an extraordinary event has occurred or is ongoing that has had a material effect on the market for the OTC Equity Security or has caused or has the potential to cause major disruption to the marketplace and/or significant uncertainty in the settlement and clearance process); or
SEC Trading Suspension
FINRA will not halt trading for the dissemination of OTC issuer news. For any questions or issues related to the halts, please contact FINRA Operations Department at (866) 776-0800

More info from the FINRA Rule 6660 regulation itself about what is deemed extraordinary event ot not:

Nor will the authority be used to correct informational imbalances
resulting from corporate news about the issuer—e.g., financial results, release of new
product, or pending regulatory investigation....

That's the way I read it